Tina Nova

Tina Nova

Chairman chez EXAGEN INC.

Fortune : 818 834 $ au 31/03/2024

70 ans
Health Technology
Commercial Services
Health Services

Profil

Tina Susan Nova is the founder of Ngen, Inc. (founded in 1994), Genoptix, Inc. (founded in 1999), and Nanogen (founded in 1994).
She held the title of President & Chief Operating Officer at Ngen, Inc. and Nanogen, and President, Chief Executive Officer & Director at Genoptix, Inc. Her current job(s) include being the Chief Executive Officer & Director at GenomeDx, Inc. (California) since 2018, Executive Chairman at Exagen, Inc. since 2019, Vice Chairman at Rady Pediatric Genomics & Systems Medicine Institute, Independent Director at Azenta, Inc. since 2023, Director at Viridos, Inc. since 2016, Director at Xequel Bio, Inc., Venture Partner at Tullis Health Investors, Inc., Trustee at the University of San Diego, and Trustee at UC San Diego Foundation.
Her former job(s) include being the President, Chief Executive Officer & Director at Veracyte SD, Inc. from 2018 to 2021, President & Chief Executive Officer at Molecular Stethoscope, Inc. from 2015 to 2019, Chairman at BIOCOM from 2001 to 2002, Executive Director-New Leads Discovery at Ligand Pharmaceuticals, Inc. from 1988 to 1992, Director at Cypress Bioscience, Inc. and Heska Corp., Lead Independent Director at Arena Pharmaceuticals, Inc. from 2004 to 2022, Independent Director at OpGen, Inc. from 2017 to 2020, Independent Director at Veracyte, Inc. from 2015 to 2021, Independent Director at NanoString Technologies, Inc., Director at CONNECT, Independent Director at DMK Pharmaceuticals Corp.
from 2011 to 2014, Independent Non-Executive Director at Olink Holding AB from 2021 to 2022, Senior Vice President & GM-Oncology Business at Illumina, Inc. from 2014 to 2015, General Manager-Urologic Cancers at Veracyte, Inc. from 2021 to 2023, and Chief Operating Officer at Selective Genetics, Inc. from 1992 to 1994.
She obtained an undergraduate degree from the University of California, Irvine and a doctorate degree from the University of California, Riverside.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
31/03/2023 20 442 ( 0,03% ) 452 995 $ 31/03/2024
12/02/2024 6 069 ( 0,01% ) 365 839 $ 31/03/2024
15/06/2023 0 ( -.--% ) - $ 31/03/2024

Postes actifs de Tina Nova

SociétésPosteDébut
EXAGEN INC. Chairman 19/01/2023
AZENTA, INC. Director/Board Member 31/01/2023
Director/Board Member -
Director/Board Member -
Private Equity Investor -
Chief Executive Officer 01/08/2018
Director/Board Member 09/11/2016
Rady Pediatric Genomics & Systems Medicine Institute Director/Board Member -
University of San Diego Director/Board Member -
Tous les postes actifs de Tina Nova

Anciens postes connus de Tina Nova

SociétésPosteFin
░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░ -
░░░░░░░░ ░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Tina Nova

Formation de Tina Nova

University of California, Irvine Undergraduate Degree
University of California, Riverside Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Tina Nova

Relations

100 +

Relations au 1er degré

29

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées9
LIGAND PHARMACEUTICALS INCORPORATED

Health Technology

AZENTA, INC.

Health Services

ILLUMINA, INC.

Health Technology

OPGEN, INC.

Commercial Services

VERACYTE, INC.

Health Technology

EXAGEN INC.

Health Services

NANOSTRING TECHNOLOGIES, INC.

Health Technology

DMK PHARMACEUTICALS CORPORATION

Health Technology

OLINK HOLDING AB

Health Technology

Entreprise privées17

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Finance

Health Technology

Commercial Services

Commercial Services

Commercial Services

Health Services

Rady Pediatric Genomics & Systems Medicine Institute

Commercial Services

Miscellaneous

Health Technology

Voir les connexions sociétés